1-(3-Methyl-1-Phenyl-5-Pyrazolyl)piperazinum CAS 401566-79-8 Puritas >99.5% (HPLC) Teneligliptin HBr Intermedia Factory
Copia Teneligliptin Hydrobromide Related media Cum High Munditia
Teneligliptin Hydrobromide CAS 906093-29-6
1-(3-Methyl-1-Phenyl-5-Pyrazolyl)piperazinum CAS 401566-79-8
Teneligliptin Hydrobromide Intermediate CAS 401564-36-1
Nomen chemicum | 1-(3-Methyl-1-Phenyl-5-Pyrazolyl)piperazine |
Synonyma | 1-(3-Methyl-1-Phenyl-1H-Pyrazol-5-yl)piperazine;Teneligliptin Impurity A |
CAS Number | 401566-79-8 |
CATTUS Number | RF-PI1817 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C14H18N4 |
M. Pondus | 242.32 |
Density | 1.19 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Off-White ad lux Brown solidus |
Lepidium sativum | IR;HPLC RT |
Damnum in Siccatio | <0.50% |
Puritas / Analysis Methodus | >99.5% (by HPLC) |
Assay | >99.5% (On Arida Basis) |
una immunditia | <0.50% |
Test Standard | Enterprise Standard |
Consuetudinem | Intermedia Teneligliptin HBr (CAS: 906093-29-6) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
1-(3-Methyl-1-Phenyl-5-Pyrazolyl)piperazinum (CAS: 401566-79-8) media est usus ad Teneligliptin HBr (CAS: 906093-29-6).Teneligliptin HBr est DPP-IV inhibitor qui in Iaponia anno 2012 probatus est ad tractationem diabetis speciei II.Teneligliptin HBr inventa et evoluta a Mitsubishi Tanabe Pharma sub nomine artis Tenelia®.Similia aliis inhibitoribus venalibus DPP-4, Teneligliptin in omnibus studiis bene toleratum fuit et QD dosing actionem inhibendi contra DPP-4 produxit diuturnam et incrementum in gradus activorum GLP-1, cum infimae rates excretionis renalis.